MOSCOW – Russia plans to sign the VACCINE opposed to COVID-19 at one point until October 15, taSS news firm reported on Tuesday, and mentioned Russian customer protection regulator Rospotrebnadzor.
The vaccine evolved through the Siberian Vector Institute, which last week ended initial human clinical trials.
Russia registered its first candidate vaccine, developed through the Gamaleya Institute in Moscow, in August. Advanced trials involving at least 40,000 other people (report via Maria Kannedova; written through Polina Ivanova; edited through Jason Neely) are being conducted.
Sign up for news from the National Post, a department of Postmedia Network Inc.
An error has occurred, provide a valid email address.
A welcome email is on the way. If you don’t see it, check your unwanted folder.
The next factor in the newsletter will soon be in your inbox.
We found a challenge when you signed up. Visit him again.
Postmedia is committed to maintaining an even civil discussion forum and encouraging all readers to express their views on our articles. Comments can take up to an hour to moderate before appearing on the site. I’ve enabled email notifications. You will now receive an email if you get a reaction to your comment, an update to a comment thread that follows, or if a user follows it. See our network regulations for more data and key points on how to adjust your email settings.
365 Bloor Street East, Toronto, Ontario, M4W 3L4
© 2020 National Post, a department of Postmedia Network Inc. All Rights Reserved. Unauthorized dissemination, transmission or transmission is strictly prohibited.
This uses cookies to personalize your content (including ads) and allows us to analyze our traffic. Learn more about cookies here. By using our site, you agree to our terms of use and our privacy policy.